| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0385613993886001 | -0.23732069 |
| NSC 294961 | 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one | 0.0385613993886001 | -0.28845852 |
| NSC 328410 | Camptothecin Derivative | 0.0385613993886001 | -0.11707774 |
| NSC 32951 | Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone | 0.0385613993886001 | -0.081495478 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.0385613993886001 | -0.32660372 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0385613993886001 | -0.27697096 |
| NSC 371777 | Null | 0.0385613993886001 | -0.15272321 |
| NSC 39215 | Null | 0.0385613993886001 | -0.22237503 |
| NSC 40618 | Cyclohexanone, 2,6-dibenzylidene- (8CI) | 0.0385613993886001 | -0.25617238 |
| NSC 409749 | Null | 0.0385613993886001 | -0.060546551 |